APA

Davidson J. A., Cromwell I., Ellard S. L., Lohrisch C., Gelmon K. A., Shenkier T., Villa D., Lim H., Sun S., Taylor S., Taylor M., Czerkawski B., Hayes M., Ionescu D. N., Yoshizawa C., Chao C., Peacock S. & Chia S. K. (20140701). A prospective clinical utility and pharmacoeconomic study of the impact of the 21-gene Recurrence Score® assay in oestrogen receptor positive node negative breast cancer. : European journal of cancer (Oxford, England : 1990).

Chicago

Davidson J A, Cromwell I, Ellard S L, Lohrisch C, Gelmon K A, Shenkier T, Villa D, Lim H, Sun S, Taylor S, Taylor M, Czerkawski B, Hayes M, Ionescu D N, Yoshizawa C, Chao C, Peacock S and Chia S K. 20140701. A prospective clinical utility and pharmacoeconomic study of the impact of the 21-gene Recurrence Score® assay in oestrogen receptor positive node negative breast cancer. : European journal of cancer (Oxford, England : 1990).

Harvard

Davidson J. A., Cromwell I., Ellard S. L., Lohrisch C., Gelmon K. A., Shenkier T., Villa D., Lim H., Sun S., Taylor S., Taylor M., Czerkawski B., Hayes M., Ionescu D. N., Yoshizawa C., Chao C., Peacock S. and Chia S. K. (20140701). A prospective clinical utility and pharmacoeconomic study of the impact of the 21-gene Recurrence Score® assay in oestrogen receptor positive node negative breast cancer. : European journal of cancer (Oxford, England : 1990).

MLA

Davidson J A, Cromwell I, Ellard S L, Lohrisch C, Gelmon K A, Shenkier T, Villa D, Lim H, Sun S, Taylor S, Taylor M, Czerkawski B, Hayes M, Ionescu D N, Yoshizawa C, Chao C, Peacock S and Chia S K. A prospective clinical utility and pharmacoeconomic study of the impact of the 21-gene Recurrence Score® assay in oestrogen receptor positive node negative breast cancer. : European journal of cancer (Oxford, England : 1990). 20140701.